Literature DB >> 19120382

The structural landscape of the health care system for breast cancer care: results from the Los Angeles Women's Health Study.

Diana M Tisnado1, Jennifer L Malin, May L Tao, Patricia Ganz, Danielle Rose-Ash, Ashlee F Hu, John Adams, Katherine L Kahn.   

Abstract

The structure of health care has been rapidly evolving in response to financial pressures and demands to improve quality. Little work has documented the structure of care and its impact in the context of breast cancer care. We conducted a survey to characterize Los Angeles physicians caring for breast cancer patients and the structural landscape of the healthcare system in which they practice. Cross-sectional survey of physicians who treated a population-based cohort of breast cancer patients. We surveyed 477 physicians, targeting all Los Angeles County medical oncologists, radiation oncologists, and surgeons reported by patients participating in the Los Angeles Women's Health Study (77% response rate). Specialty-specific questionnaires were developed. Items were based on the structure and quality of care literature, cognitive interviews with cancer care specialists, and existing physician survey instruments. Breast cancer care providers in Los Angeles are diverse, with one-third non-white and 46% speaking a non-English language. Group practice is most common, (37% single specialty, 16% group-model HMO, 8% multi-specialty group). Minimal teaching involvement predominates. Mean new breast cancer patient volumes are relatively high (8 per month overall; six for surgeons), representing 46% of new cancer patients. Physicians reported high career satisfaction levels (83-92%). Physicians were least satisfied with the amount of time spent with patients (82%). Data from this study represent important building blocks for further analyses to determine the impact of structural characteristics on the quality of care that breast cancer patient's experience.

Entities:  

Mesh:

Year:  2008        PMID: 19120382      PMCID: PMC2810106          DOI: 10.1111/j.1524-4741.2008.00666.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  44 in total

1.  Quality improvement in chronic illness care: a collaborative approach.

Authors:  E H Wagner; R E Glasgow; C Davis; A E Bonomi; L Provost; D McCulloch; P Carver; C Sixta
Journal:  Jt Comm J Qual Improv       Date:  2001-02

2.  Breast cancer outcomes among older women: HMO, fee-for-service, and delivery system comparisons.

Authors:  A Lee-Feldstein; P J Feldstein; T Buchmueller; G Katterhagen
Journal:  J Gen Intern Med       Date:  2001-03       Impact factor: 5.128

3.  Personal, organizational, and market level influences on physicians' practice patterns: results of a national survey of primary care physicians.

Authors:  B E Landon; J Reschovsky; M Reed; D Blumenthal
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

4.  The relationship of membership in research networks to compliance with treatment guidelines for early-stage breast cancer.

Authors:  Linda Laliberte; Mary L Fennell; George Papandonatos
Journal:  Med Care       Date:  2005-05       Impact factor: 2.983

5.  Impact of breast cancer treatment guidelines on surgeon practice patterns: results of a hospital-based intervention.

Authors:  V Mor; L L Laliberte; A C Petrisek; O Intrator; T Wachtel; P G Maddock; K I Bland
Journal:  Surgery       Date:  2000-11       Impact factor: 3.982

6.  Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison.

Authors:  G F Riley; A L Potosky; C N Klabunde; J L Warren; R Ballard-Barbash
Journal:  JAMA       Date:  1999-02-24       Impact factor: 56.272

7.  Patterns and correlates of patient referral to surgeons for treatment of breast cancer.

Authors:  Steven J Katz; Timothy P Hofer; Sarah Hawley; Paula M Lantz; Nancy K Janz; Kendra Schwartz; Lihua Liu; Dennis Deapen; Monica Morrow
Journal:  J Clin Oncol       Date:  2007-01-20       Impact factor: 44.544

8.  Treatment differences and other prognostic factors related to breast cancer survival. Delivery systems and medical outcomes.

Authors:  A Lee-Feldstein; H Anton-Culver; P J Feldstein
Journal:  JAMA       Date:  1994-04-20       Impact factor: 56.272

9.  Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland.

Authors:  C R Gillis; D J Hole
Journal:  BMJ       Date:  1996-01-20

10.  Decentralization of breast cancer surgery in the United States.

Authors:  Joan M Neuner; Mary Ann Gilligan; Rodney Sparapani; Purushottam W Laud; David Haggstrom; Ann B Nattinger
Journal:  Cancer       Date:  2004-09-15       Impact factor: 6.860

View more
  4 in total

1.  Physician and Practice Characteristics Influencing Tumor Board Attendance: Results From the Provider Survey of the Los Angeles Women's Health Study.

Authors:  Kevin S Scher; Diana M Tisnado; Danielle E Rose; John Lloyd Adams; Clifford Y Ko; Jennifer L Malin; Patricia A Ganz; Katherine L Kahn
Journal:  J Oncol Pract       Date:  2011-03       Impact factor: 3.840

2.  Prevalence, predictors, and patient outcomes associated with physician co-management: findings from the Los Angeles Women's Health Study.

Authors:  Danielle E Rose; Diana M Tisnado; May L Tao; Jennifer L Malin; John L Adams; Patricia A Ganz; Katherine L Kahn
Journal:  Health Serv Res       Date:  2011-12-15       Impact factor: 3.402

3.  Use of interpreters by physicians treating limited English proficient women with breast cancer: results from the provider survey of the Los Angeles Women's Health Study.

Authors:  Danielle E Rose; Diana M Tisnado; Jennifer L Malin; May L Tao; Melinda A Maggard; John Adams; Patricia A Ganz; Katherine L Kahn
Journal:  Health Serv Res       Date:  2009-10-29       Impact factor: 3.402

4.  Financial incentives for quality in breast cancer care.

Authors:  Diana M Tisnado; Danielle E Rose-Ash; Jennifer L Malin; John L Adams; Patricia A Ganz; Katherine L Kahn
Journal:  Am J Manag Care       Date:  2008-07       Impact factor: 2.229

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.